Search research articles
Contact Us
Filters
Showing results (371-380 of 457) with videos related to
Page
of 46
Sort By:
Blood
|
June 10, 2021
Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia
Yunchao Chang, Jaeki Min, Jamie A Jarusiewicz, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 17, 2023
Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment
Kashi Raj Bhattarai, Robert J Mobley, Kelly R Barnett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2024
Impact of Age on Pharmacogenomics and Treatment Outcomes of B-Cell Acute Lymphoblastic Leukemia
Satoshi Yoshimura, Zhenhua Li, Yoshihiro Gocho, et al.
Bone Marrow Transplantation
|
October 25, 2024
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia
Gege Gui, Niveditha Ravindra, Pranay S Hegde, et al.
Leukemia & Lymphoma
|
March 12, 2020
Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis
Rachel J Bubik, Dylan M Barth, Christopher Hook, et al.
American Journal of Hematology
|
July 4, 2020
Characteristics of late transplant-associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation
Cihan Heybeli, Meera Sridharan, Hassan B Alkhateeb, et al.
Cell Reports
|
October 7, 2020
TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment
Bac Viet Le, Paulina Podszywalow-Bartnicka, Silvia Maifrede, et al.
Blood Cancer Journal
|
October 31, 2021
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia
Joshua F Zeidner, Tara L Lin, Carlos E Vigil, et al.
Nature Communications
|
May 1, 2024
Investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment
Kashi Raj Bhattarai, Robert J Mobley, Kelly R Barnett, et al.
Nature Cancer
|
June 27, 2025
Multipotent lineage potential in B cell acute lymphoblastic leukemia is associated with distinct cellular origins and clinical features
Ilaria Iacobucci, Andy G X Zeng, Qingsong Gao, et al.
Page
of 46
Search research articles
Search
Showing results (371-380 of 457) with videos related to
Sort By:
Page
of 46
Blood
|
June 10, 2021
Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia
Yunchao Chang, Jaeki Min, Jamie A Jarusiewicz, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 17, 2023
Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment
Kashi Raj Bhattarai, Robert J Mobley, Kelly R Barnett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2024
Impact of Age on Pharmacogenomics and Treatment Outcomes of B-Cell Acute Lymphoblastic Leukemia
Satoshi Yoshimura, Zhenhua Li, Yoshihiro Gocho, et al.
Bone Marrow Transplantation
|
October 25, 2024
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia
Gege Gui, Niveditha Ravindra, Pranay S Hegde, et al.
Leukemia & Lymphoma
|
March 12, 2020
Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis
Rachel J Bubik, Dylan M Barth, Christopher Hook, et al.
American Journal of Hematology
|
July 4, 2020
Characteristics of late transplant-associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation
Cihan Heybeli, Meera Sridharan, Hassan B Alkhateeb, et al.
Cell Reports
|
October 7, 2020
TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment
Bac Viet Le, Paulina Podszywalow-Bartnicka, Silvia Maifrede, et al.
Blood Cancer Journal
|
October 31, 2021
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia
Joshua F Zeidner, Tara L Lin, Carlos E Vigil, et al.
Nature Communications
|
May 1, 2024
Investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment
Kashi Raj Bhattarai, Robert J Mobley, Kelly R Barnett, et al.
Nature Cancer
|
June 27, 2025
Multipotent lineage potential in B cell acute lymphoblastic leukemia is associated with distinct cellular origins and clinical features
Ilaria Iacobucci, Andy G X Zeng, Qingsong Gao, et al.
Page
of 46